Kun M.

Kun M. has extensive experience in the healthcare and biotechnology sectors, currently serving as a Senior Advisor at BioConnexUS since January 2017 and as President of the Sino-US Diabetes Consortium Inc since 2015, focusing on diabetes research, clinical care, and product development. Previously, Kun held the position of VP of Science & Technology at AIT Laboratories, overseeing new product development and lab operations, and served as Part-time President & CEO at University Health Management (China) from 2012 to 2014. Additional roles include Director at CHV Capital, Inc., Senior Associate at Clarian Health Ventures, and Business Development Manager at IURTC. Kun began a career in research as a Research Associate at the National Key Laboratory of Molecular Virology and Genetic Engineering. Educational qualifications include an MBA in Finance and Strategy from Washington University in St. Louis, a Ph.D. from Indiana University School of Medicine, and a Bachelor of Medicine from Peking University Health Science Center.